3 reports

Company ## ##. ##. ##.

  • Biopharmaceutical
  • Gene Therapy
  • Medical Biotechnology
  • France
  • Market Size
  • APR 26, 2018: GENSIGHT BIOLOGICS TO PRESENT DATA ON GS010 AT THE ANNUAL MEETING OF ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY
  • GENSIGHT BIOLOGICS RAISES USD25 MILLION IN PRIVATE PLACEMENT OF SHARES

Bernard Gilly, CEO of GenSight Biologics, said, " Gene therapy is coming of age and ophthalmology is one of the most promising indications in particular because of the safety and efficacy demonstrated in certain trials.

  • Gene Therapy
  • Ophthalmology
  • France
  • Company
  • GenSight Biologics S.A.
  • Apr 17, 2017: New step towards the treatment of myotubular myopathy: gene therapy restores strength and prolongs lives in affected dogs
  • SELECTA BIOSCIENCES ENTERS INTO RESEARCH AGREEMENT WITH GENETHON

The company offers AVXS-##, a proprietary gene therapy candidate in phase ## targeted at the treatment of spinal muscular atrophy.

  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • France
  • GenSight Biologics S.A.